INTRODUCTION 2
Exercise-induced bronchoconstriction (EIB) describes the phenomenon of acute, transient 3 airway narrowing in association with physical activity [1] and is highly prevalent in both 4 recreational and elite level athletes [2, 3] . Although the precise pathogenesis of EIB is not 5 completely understood, it is generally acknowledged that exercise hyperpnea initiates 6 bronchoconstriction by inducing osmotic changes at the distal airway surface [4] . This 7 precipitates the release of pro-inflammatory mediators including histamine, neuropeptides, 8 cytokines, cysteinyl leukotrienes and prostaglandins, ultimately resulting in airway smooth 9 muscle contraction [5] . In the chronic setting, repeated, prolonged periods of exercise 10 hyperpnea have been associated with injury-repair cycling of the airway epithelium resulting 11 in smooth muscle remodelling [6, 7] and the development of EIB in athletes [2] . 12
The mainstay of treatment for EIB consists of pharmacological medication (e.g. short acting 13 inhaled beta-2 agonists (SABA)) [1] . However, there is accumulating evidence that non-14 pharmacological interventions, such as dietary modification, may have utility in the treatment 15 of EIB in athletes [8] . This is pertinent given the possible side effects of chronic beta-2 16 agonist therapy (e.g. development of tachyphlaxis and degenerative changes in lung function) 17 [9] . One of the most promising dietary interventions is fish oil supplementation. Specifically, 18 omega-3 polyunsaturated fatty acids (PUFA) (eicosapentaenoic acid (EPA) and 19 docosahexaenoic acid (DHA)) have previously been shown to attenuate airway inflammation 20 and the bronchoconstrictor response to exercise hyperpnea [10, 11] . The purported therapeutic 21 effect of omega-3 PUFA for the treatment of EIB in athletes is biologically plausible; 22 however the findings to date remain equivocal [10] [11] [12] [13] [14] [15] [16] . The proposed mechanism of omega-3 23 PUFA protecting against EIB consists of EPA and DHA competitively inhibiting arachidonic 24 acid metabolism and therefore reducing the generation of pro-inflammatory leukotrienes, 25 prostaglandins and cytokine production from inflammatory cells [17] . 26 Indeed, other dietary interventions may also be important. Recently, epidemiological studies 27 have highlighted a direct association between vitamin D deficiency and the incidence and 28 severity of asthma [18] . Although the evidence is sparse, low serum vitamin D levels have 29 previously been associated with reduced lung function and increased airways hyper-reactivity 30 to exercise in asthmatic children with EIB [19] 
Urinary inflammatory markers 124
Enzyme immunoassays of LTE4 and 9α, 11β-prostaglandin F2 were performed in serially 125 diluted urine (Cayman Chemical Company, Ann Arbor, MI) as previously described [36, 37] . 126
Inter-and intra-assay coefficient of variation was <10%. All data were normalised and 127 presented as nanograms of excreted mediator per millimole of creatinine. Creatinine analyses 128
were performed using a modification of Jaffe's creatinine protocol [38] . 129
Nutrient intake and compliance 130
Subjects were instructed to maintain their usual diet (maximum of one fish meal per week) 131 and physical activity levels throughout the duration of the study. Adherence to treatment 132 regimens was monitored by athletes documenting the time and date of consumption and 133 returning any supplements that were not consumed. In accordance with comparable research 134 a compliance of ≥90% was considered acceptable [36] . 135
Statistical analysis 136
Normality of data was assessed using a Kolmogorov-Smirnov test and Levene's test to check 137 for homogeneity of variance between groups. A two-way repeated measures analysis of 138 variance (ANOVA) was used to analyse within subject effects. Mauchly's test was conducted 139 to determine if sphericity was violated. If sphericity was violated, the repeated measures 140 ANOVA was corrected using a Greenhouse-Geisser adjustment factor. expressed as mean (± SD) and significance was set at P < 0.05. 148
149

RESULTS
150
Baseline characteristics, allergy and pre-challenge lung function 151
Ten recreational athletes (male: n = 9) completed the study. Subjects' characteristics are 152 presented in Table 1 . Eight athletes were atopic to skin prick testing and eight had a positive 153 (≥5) AQUA questionnaire. Seven athletes with a positive AQUA questionnaire were also 154 atopic and therefore considered allergic. Five subjects reported respiratory symptoms (e.g. 155 cough, wheeze, dyspnea etc.) in association with exercise. All pulmonary function measures 156 were within normal predicted limits with no evidence of airflow obstruction. In addition, no 157 difference in resting lung function was observed between visits (P>0.05) ( Table 2) . 158
Compliance to treatment regimens 159
Excellent adherence to treatment regimens was reported for placebo and vitamin D + omega-160 3 PUFA (99.5 ± 1.1% and 98.5 ± 3.4%) diets, respectively (P>0.05). PEF (% predicted) 97.7 ± 13.7 100.6 ± 7.9 97.9 ± 11.5 Mean ± SD 96.5 ± 15.4 -15.9 ± 3.6 -16.1 ± 6.1 -17.8 ± 7.2 
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